CD8A and neoplasm: Pinz et al. developed a CD4-directed CAR T-cell product in which CD4-CAR T-cells maintained a central memory stem cell-like phenotype (CD8+CD45RO+CD62L), demonstrated anti-tumor responses against CD4+ lymphoma cells, and led to prolonged mouse survival [87].